This suggests that loss of 53BP1 expression may be an accompanying molecular change and may be required for the BCCIP-deficient benign lesions to evolve into malignant tumors, which would resemble the relationship between BRCA1 and 53BP1 in tumor development [7, 45–47]. Here, BRCA1 is linked to neoplasm.